Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the...

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Oxidative Stress Biology

Background:

• Advanced coronary artery disease (CAD) lacks effective treatments for non-stentable/bypassable patients.
• Extracellular vesicles (EVs), particularly hypoxia-conditioned EVs (HEVs), show therapeutic potential for CAD.
• Previous studies indicated HEVs improve perfusion, reduce inflammation, and decrease apoptosis in ischemic myocardium.

Purpose of the Study:

• To investigate the impact of HEVs on oxidative stress in a swine model of chronic myocardial ischemia.
• To elucidate the role of HEVs in redox signaling pathways within the ischemic heart.

Main Methods:

• A swine model of chronic myocardial ischemia was established using an ameroid constrictor.
• Hypoxia-conditioned EVs (HEVs) or saline control were injected into the ischemic myocardium.
• Protein expression of antioxidants and oxidative stress markers was quantified via immunoblotting, OxyBlot, and 3-nitrotyrosine staining.

Main Results:

• HEV administration significantly increased myocardial expression of key antioxidants (SOD2, GPX-1, HSF-1, UCP-2, catalase, HO-1) and pro-oxidants (NOX1, NOX3, p47phox, p67phox).
• No significant changes were observed in NFkB, KEAP1, or PRDX1 expression.
• Total oxidative stress, measured by OxyBlot and 3-nitrotyrosine staining, showed no significant difference between HEV and control groups.

Conclusions:

• HEVs induce significant increases in both pro-oxidant and antioxidant proteins in ischemic myocardium without altering the net oxidative stress.
• These redox signaling pathway alterations suggest a mechanism for HEV-mediated improvements in perfusion, inflammation, and apoptosis.
• Further research is needed to determine if HEVs affect net oxidative stress at earlier time points post-administration.